The PatientsLikeMe community is helping to unlock answers we need to fight ALS and Parkinson's
PatientsLikeMe, in partnership with Denali Pharmaceuticals, is underway with a pilot study to evaluate the biological signatures of ALS and Parkinson's and to support the development of a potential new treatment for neurodegeneration.
This study is different than others you may have read about or participated in. It’s focused on comparing ALS and Parkinson's to other conditions, not just controls. And it will use new approaches to connect biomarkers in your blood to your experience with disease, potentially revealing more about how diseases develop in the body.
ALS patients and Parkinson's patients who’ve joined our free website to share their health data and track their progress are now collaborating on a new journey of discovery. Together we'll help unlock new answers in our understanding of these diseases. Because the more we know, the more we can do to fight them.
We’re no longer enrolling patients in this study. However, if participating in new kinds of research is something you’re interested in, we do have another opportunity to join us in transforming the future of personalized health. It’s called DigitalMe™ and you can learn more about it here.